The fusion of viral and cellular membranes, an event known to be promoted by a number of viral fusion proteins, is both a fundamental part of the viral life cycle and a paradigm for other membrane fusion events. The well-characterized influenza hemagglutinin protein promotes fusion after undergoing a low pH induced conformational change. However, many viral fusion events occur at neutral pH, and the mechanisms and factors involved in triggering neutral pH fusion remain elusive. It is proposed to study the neutral pH fusion event by further examination of fusion promoted by the F protein of the prototypic paramyxovirus SV5. Quantitative fusion assays measuring both lipid and cellular contents mixing will be employed to examine the effects of factors such as temperature and lipid content on the rate and extent of fusion promoted by both the wild type SV5 F protein and a mutant F protein which has been shown to promote enhanced syncytia formation. To obtain a soluble F protein for biochemical and structural characterization, an F protein in which the transmembrane and cytoplasmic tail domains has been replaced by the signal sequence for a lipid anchor will be created. The fusion characteristics of the lipid-anchored F protein will be examined, and the solubilized ectodomain fragment will be purified. Finally, the compelling hypothesis that F protein undergoes a conformational change related to fusion will be examined using a variety of methods, including protease sensitivity, CD and tyrosine fluorescence spectroscopy, and reaction with anti-peptide antibodies. A detectable conformational change will be used to assay for factors that induce these changes, and thus trigger fusion.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Postdoctoral Individual National Research Service Award (F32)
Project #
5F32AI009607-03
Application #
2837340
Study Section
Virology Study Section (VR)
Program Officer
Lambert, Linda C
Project Start
1998-12-01
Project End
Budget Start
1998-12-01
Budget End
1999-11-30
Support Year
3
Fiscal Year
1999
Total Cost
Indirect Cost
Name
Northwestern University at Chicago
Department
Biochemistry
Type
Schools of Dentistry
DUNS #
005436803
City
Chicago
State
IL
Country
United States
Zip Code
60611
Chai, Qian; Wang, Zhaoshuai; Webb, Stacy R et al. (2016) The ssrA-Tag Facilitated Degradation of an Integral Membrane Protein. Biochemistry 55:2301-4
Dutch, R E; Hagglund, R N; Nagel, M A et al. (2001) Paramyxovirus fusion (F) protein: a conformational change on cleavage activation. Virology 281:138-50
Dutch, R E; Lamb, R A (2001) Deletion of the cytoplasmic tail of the fusion protein of the paramyxovirus simian virus 5 affects fusion pore enlargement. J Virol 75:5363-9
Dutch, R E; Jardetzky, T S; Lamb, R A (2000) Virus membrane fusion proteins: biological machines that undergo a metamorphosis. Biosci Rep 20:597-612
Lamb, R A; Joshi, S B; Dutch, R E (1999) The paramyxovirus fusion protein forms an extremely stable core trimer: structural parallels to influenza virus haemagglutinin and HIV-1 gp41. Mol Membr Biol 16:11-9
Dutch, R E; Leser, G P; Lamb, R A (1999) Paramyxovirus fusion protein: characterization of the core trimer, a rod-shaped complex with helices in anti-parallel orientation. Virology 254:147-59
Baker, K A; Dutch, R E; Lamb, R A et al. (1999) Structural basis for paramyxovirus-mediated membrane fusion. Mol Cell 3:309-19
Joshi, S B; Dutch, R E; Lamb, R A (1998) A core trimer of the paramyxovirus fusion protein: parallels to influenza virus hemagglutinin and HIV-1 gp41. Virology 248:20-34
Dutch, R E; Joshi, S B; Lamb, R A (1998) Membrane fusion promoted by increasing surface densities of the paramyxovirus F and HN proteins: comparison of fusion reactions mediated by simian virus 5 F, human parainfluenza virus type 3 F, and influenza virus HA. J Virol 72:7745-53
Zhou, J; Dutch, R E; Lamb, R A (1997) Proper spacing between heptad repeat B and the transmembrane domain boundary of the paramyxovirus SV5 F protein is critical for biological activity. Virology 239:327-39